BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/28/2024 4:34:22 AM | Browse: 204 | Download: 1153
 |
Received |
|
2024-07-01 04:19 |
|
Peer-Review Started |
|
2024-07-02 06:25 |
|
First Decision by Editorial Office Director |
|
2024-08-04 06:13 |
|
Return for Revision |
|
2024-08-04 08:57 |
|
Revised |
|
2024-08-12 03:58 |
|
Publication Fee Transferred |
|
2024-09-03 08:26 |
|
Second Decision by Editor |
|
2024-09-02 02:41 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-09-02 07:45 |
|
Articles in Press |
|
2024-09-02 07:45 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-09-09 00:47 |
|
Publish the Manuscript Online |
|
2024-09-28 04:34 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Comparison of efficacy and safety of nab-paclitaxel and oxaliplatin + S-1 and standard S-1 and oxaliplatin chemotherapy regimens for treatment of gastric cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yi-Cong Wang, Long Feng, Gong-Ping Wang, Peng-Jie Yu, Can Guo, Bao-Jia Cai, Yan Song, Ting Pan, Bo-Hao Lin, Yuan-Dong Li and Jing-jing Xiao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| The Department of Science and Technology of Qinghai Province |
2018-SF-113 |
| "Kunlun Talents-Plateau Famous Doctors" Project in Qinghai Province |
|
|
| Corresponding Author |
Peng-Jie Yu, Doctor, DPhil, PhD, Deputy Director, Research Fellow, Surgeon, Department of Gastrointestinal Surgery, The Affiliated Hospital of Qinghai University, No. 29 Tongren Road, Xining 810000, Qinghai Province, China. hnypj768@126.com |
| Key Words |
Nab-paclitaxel; Gastric cancer; Efficacy; Safety |
| Core Tip |
NaB-paclitaxel combined with oxaliplatin + S-1 (P-SOX) regimen is superior to conventional SOX regimen in the treatment of gastric cancer. Progression-free survival was associated with effective perioperative chemotherapy (Response Evaluation Criteria in Solid Tumors 1.1, Tumor Regression Grade), tumor diameter ≤ 2 cm, high differentiation, and early cTNM staging. |
| Publish Date |
2024-09-28 04:34 |
| Citation |
Wang YC, Feng L, Wang GP, Yu PJ, Guo C, Cai BJ, Song Y, Pan T, Lin BH, Li YD, Xiao JJ. Comparison of efficacy and safety of nab-paclitaxel and oxaliplatin + S-1 and standard S-1 and oxaliplatin chemotherapy regimens for treatment of gastric cancer. World J Gastrointest Surg 2024; 16(10): 3224-3238
|
| URL |
https://www.wjgnet.com/1948-9366/full/v16/i10/3224.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v16.i10.3224 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
